Cromolyn Sodium Inhalation Solution
CROMOLYN SODIUM INHALATION SOLUTION, USP
Approved
Approval ID
1fecdab8-08cb-4b08-89a3-9e0180a4350f
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 17, 2024
Manufacturers
FDA
VIRTUS PHARMACEUTICALS LLC
DUNS: 079659493
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Cromolyn Sodium Inhalation
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code69543-456
Application NumberANDA075437
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cromolyn Sodium Inhalation
Product Specifications
Route of AdministrationINTRABRONCHIAL
Effective DateJanuary 17, 2024
FDA Product Classification
INGREDIENTS (2)
CROMOLYN SODIUMActive
Quantity: 20 mg in 2 mL
Code: Q2WXR1I0PK
Classification: ACTIB
WATERInactive
Code: 059QF0KO0R
Classification: IACT